🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us in September on the The Lancet Rheumatology Summit on sex and gender #rheumatologi with a great program

Very happy to share our review on recent advances in the management of ILD in systemic sclerosis with Oliver Distler, Katerina Antoniou Bruno Crestani CO Pulmonary Med journals.lww.com/co-pulmonaryme…

Last few days to join our expert speakers at #LancetSummitRheum: Registration deadline for live participation is 12 noon BST Wednesday, Sept 21, 2022. bit.ly/LSRHEUM

#MOTTIRL with dear and competent Anna Hoffmann-Vold, a rheumatologist specialized in Interstitial Lung Disease in autoimmune rheumatic diseases #iclaf2022 Lot's in common here, so nice to meet you in person, Anna 🇧🇻❤️🇧🇷

Join the Northern Ireland and Manchester ILD conference.

Exciting days at #ACR22 with great scientific sessions and meeting wonderful friends again, this evening at the The Lancet Rheumatology reception with Anna and Heather and finally meeting lovely @DrPujaMehta1

Amazing to meet again in person #ACR22 with Elisabeth UCLA and Jeska❤️

Important work presented at #ACR by amazin Hilde Jenssen Bjørkekjær using EUSTAR data medpagetoday.com/meetingcoverag…

Today is international day for women in science. #womeninscience Very happy to be one of them👩🏻‍⚕️👩🏻‍🔬

Very happy to share our recent paper assessing enrichment strategies for progressive ILD in systemic sclerosis in EUSTAR published in Chest CHEST EUSTAR sciencedirect.com/science/articl…

´Clinical Trial Simulations in Pulmonary Fibrosis - patient focused insights adaptations’. Delighted our paper is just out in ERJ Open Research DOI: 10.1183/ 23120541.00602-2022. Toby Maher @IPFWarrior Sharon Lee Maxine Flewett Anna Hoffmann-Vold Michael Kreuter Boehringer Ingelheim #CurePF

My 1st in-person talks in Europe after 4 years‼️ Thursday: Pathophysiology of ILD - Lessons & implications for therapy from Single Cell profiles of the IPF Lung  Friday: Pathophysiology of ILD - converging & diverging immune pathways in fibrotic lung disease U of Zurich & hybrid

Very proud of Hilde Jenssen Bjørkekjær for her amazing PhD work and the interview Andrew Crookston #ACR23

Thank you American College of Rheumatology for great days in San Diego, meeting friends and colleagues, discussing and smiling. So glad we can meet onsite again🥰 @Juge_P_A Hilde Jenssen Bjørkekjær Cosimo Bruni Unispital_USZ Oslounivsykehus

Thank you EULAR for an amazing and inspiring week and the invitation to talk about “What is new in ILD” and all accepted abstract presentations from our group and EUSTAR. Very proud of our teams. Håvard fretheim, Cosimo Bruni, Hilde Jenssen Bjørkekjær, Corrado Campochiaro

📽️ Prof. Anna-Maria Hoffmann-Vold gave us a review of the most recent data from the diagnosis to the management of interstitial lung disease in RMDs at #EULAR24. -> medicaldigest.org/scientific-con… EULAR Anna Hoffmann-Vold Oslounivsykehus #Rheumatology #MedTwitter #ILD

Thanks to ERS for inviting us to talk at this fully booked postgraduate course, ILD IPF Doc: Nazia Chaudhuri Pilar Rivera-Ortega Argyris Tzouvelekis Peter George Maria Molina-Molina, George Margaritopoulps and Claudia Ravaglia

Thanks ERS for an exciting #ERSCongress🫁 and the opportunity to present findings on upfront treatment in SSc-PAH from #EUSTAR👀✅. The joint lecture by the fantastic Anna Hoffmann-Vold and her incredible colleagues showed the huge interest in the field #RheumPulm 🤩

Please join us!!!